Evaluation of diagnostic accuracy of different biomarkers for prostate cancer

Pakistan Journal of Medical Sciences

Volumn 27, Issue 1, 2011, Pages 48-51

  Asafudullah, S M ^a   Salam, M A ^a   Badruddoza, S M ^a  

^a RAJSHAHI MEDICAL COLLEGE   (Bangladesh)

Author keywords

Diagnostic accuracy; Free PSA percent; Prostate cancer; PSA; PSAD; Sensitivity; Specificity

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BANGLADESH; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL RECTAL EXAMINATION; DISEASE MARKER; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PREDICTION; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

EID: 79551528774     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fletcher CDM. 'Tumors of the male genital tract'. Diagnostic Histopathology of tumors. 3rd edition, Philadelphia, Elsevier, 2007: 755.
2. Talukder H, Jabeen S, Shaheen S, Islam MJ, Haque M. Hospital Cancer Registry, National Institute of Cancer Research and Hospital, Dhaka, Bangladesh, Annual Report 2005.
3. Ishibe T, Usui T, Nihira H. Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate. J Urol 1994;112:237-240.
4. Freedland SJ, Partin AW. Prostate-specific antigen: Update 2006. Urology 2006;67:458-460.
5. Hernandez J, Thompson IM. Prostate-Specific Antigen: A Review of the Validation of the Most Commonly Used Cancer Biomarker. Cancer 2004;101(5):894-904.
6. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL. Increased specificity of PSA screening through measurement of percent free PSA. J Urol 1995;153(Suppl 1):312.
7. Luderer AA, Chen YT, Soriano TF, Kramp WJ, Carlson. G, Cuny C, et al. Measurement of the proportion of free-to-total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995;46:187-194.
8. Curtis M, Arthur EC, Gerald PM, Georg B, Ants T, Robert B, et al. Association of Free PSA Percent, Total PSA, Age, and Gland Volume in the Detection of Prostate Cancer. The Prostate 1999;39:153-158.
9. Brassell SA, Kao T, Sun L, Moul JW. PSA versus PSAD as predictor of tumor volume, margin status, pathologic stage and biochemical recurrence of prostate cancer. Urology 2005;66:1229-1233.
10. Song JM, Kim C, Chung HC. 'Prostate specific antigen, digital rectal examination and transrectal ultrasonography: A meta-analysis for this diagnostic triad of prostate cancer in symptomatic Korean men'. Yonesi Medical J 2005;46:414-424.
11. Catalona WJ, Antenor JAV, Roehl KA. Screening for prostate cancer in high risk populations. J Urol 2002;168:1980-1983.
12. Van Cangh PJ, De Nayer P, Sauvage P, Tombal B, Elsen M, Lorge F, et al. Free to total prostate-specific antigen (PSA) ration is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer. Prostate (Suppl) 1996;7:30-34.
13. Prestigiacomo AF, Stamey TA. Can free and total prostate specific antigen and prostate volume distinguish between men with negative and positive systematic ultrasound guided prostatic biopsies. J Urol 1997;157:189-194.
14. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, et al. Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-816.
15. Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Pohl CE, Sieber PR, et al. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol 1994;51(1):88-93.